129 related articles for article (PubMed ID: 3393256)
21. Diagnostic value of serum procollagen peptide measurements in alcoholic liver disease.
Savolainen ER; Goldberg B; Leo MA; Velez M; Lieber CS
Alcohol Clin Exp Res; 1984; 8(4):384-9. PubMed ID: 6385761
[TBL] [Abstract][Full Text] [Related]
22. Effect of ethanol challenge on serum glycoproteins in alcoholic and non-alcoholic liver disease.
Cobden I; Matthewson K; Carr WP; Dick WC; Record CO
Alcohol Alcohol; 1987; 22(3):257-63. PubMed ID: 2441717
[TBL] [Abstract][Full Text] [Related]
23. The N-terminal propeptide of collagen type III in serum reflects activity and degree of fibrosis in patients with chronic liver disease.
Frei A; Zimmermann A; Weigand K
Hepatology; 1984; 4(5):830-4. PubMed ID: 6479851
[TBL] [Abstract][Full Text] [Related]
24. An immunohistochemical and serum ELISA study of type I and III procollagen aminopropeptides in primary biliary cirrhosis.
Davis BH; Madri JA
Am J Pathol; 1987 Aug; 128(2):265-75. PubMed ID: 3303951
[TBL] [Abstract][Full Text] [Related]
25. [Significance and limitations of the radioimmunologic determination of the aminoterminal peptide of procollagen III in chronic hepatopathies].
Rossi L; Degen C; Lorenzin F; Milani A; Siciliano M
Ann Ital Med Int; 1988; 3(3):203-7. PubMed ID: 3152857
[No Abstract] [Full Text] [Related]
26. Serum type III procollagen peptide and laminin (Lam-P1) detect alcoholic hepatitis in chronic alcohol abusers.
Annoni G; Colombo M; Cantaluppi MC; Khlat B; Lampertico P; Rojkind M
Hepatology; 1989 May; 9(5):693-7. PubMed ID: 2707736
[TBL] [Abstract][Full Text] [Related]
27. Serum laminin and N-terminal type III procollagen in chronic alcoholic liver disease.
González-Reimers E; Santolaria-Fernández F; Brajin-Rodríguez MM; Batista-López N
Gastroenterology; 1991 Jan; 100(1):292-4. PubMed ID: 1983844
[No Abstract] [Full Text] [Related]
28. Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C.
Guéchot J; Poupon RE; Giral P; Balkau B; Giboudeau J; Poupon R
J Hepatol; 1994 Mar; 20(3):388-93. PubMed ID: 8014451
[TBL] [Abstract][Full Text] [Related]
29. Serum type III procollagen peptide in alcoholic liver disease and idiopathic hemochromatosis: its relationship to hepatic fibrosis, activity of the disease and iron overload.
Colombo M; Annoni G; Donato MF; Conte D; Martines D; Zaramella MG; Bianchi PA; Piperno A; Tiribelli C
Hepatology; 1985; 5(3):475-9. PubMed ID: 3997075
[TBL] [Abstract][Full Text] [Related]
30. Higher levels of serum aminoterminal type III procollagen peptide, and laminin in alcoholic than in nonalcoholic cirrhosis of equal severity.
Lotterer E; Gressner AM; Kropf J; Grobe E; von Knebel D; Bircher J
J Hepatol; 1992 Jan; 14(1):71-7. PubMed ID: 1737919
[TBL] [Abstract][Full Text] [Related]
31. Serum free thyroid hormone concentrations and indices in alcoholic liver cirrhosis, primary biliary cirrhosis and chronic active hepatitis.
Liewendahl K; Helenius T; Tanner P; Salaspuro M
Acta Endocrinol Suppl (Copenh); 1983; 251():21-6. PubMed ID: 6404084
[No Abstract] [Full Text] [Related]
32. Non-invasive monitoring of oxidant stress in alcoholic liver disease.
Pemberton PW; Smith A; Warnes TW
Scand J Gastroenterol; 2005 Sep; 40(9):1102-8. PubMed ID: 16165720
[TBL] [Abstract][Full Text] [Related]
33. Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy.
Färkkilä M; Rautiainen H; Kärkkäinen P; Karvonen AL; Nurmi H; Niemelä O
Liver Int; 2008 Jul; 28(6):787-97. PubMed ID: 18397236
[TBL] [Abstract][Full Text] [Related]
34. Liver collagen mRNA and serum amino-terminal peptide of type III procollagen (PIIINP) levels in patients with alcoholic liver disease.
Leblond-Francillard M; Augereau C; Nalpas B; Trinchet JC; Hartmann DJ; Berthelot P; Beaugrand M; Brechot C
J Hepatol; 1989 Nov; 9(3):351-8. PubMed ID: 2607123
[TBL] [Abstract][Full Text] [Related]
35. Procollagen-III peptide and chronic viral C hepatitis.
Jeffers LJ; Coelho-Little ME; Cheinquer H; Vargas C; Civantos F; Alvarez L; Reddy KR; Parker T; de Medina M; Li X
Am J Gastroenterol; 1995 Sep; 90(9):1437-40. PubMed ID: 7661165
[TBL] [Abstract][Full Text] [Related]
36. Serum hyaluronan and aminoterminal propeptide of type III procollagen in primary biliary cirrhosis: relation to clinical symptoms, liver histopathology and outcome.
Nyberg A; Lindqvist U; Engström-Laurent A
J Intern Med; 1992 May; 231(5):485-91. PubMed ID: 1602286
[TBL] [Abstract][Full Text] [Related]
37. An inverse relationship between markers of fibrogenesis and collagen degradation in patients with or without alcoholic liver disease.
Koivisto H; Hietala J; Niemelä O
Am J Gastroenterol; 2007 Apr; 102(4):773-9. PubMed ID: 17222322
[TBL] [Abstract][Full Text] [Related]
38. Serial determination of type III procollagen amino propeptide serum levels in patients with histologically progressive and non-progressive primary biliary cirrhosis.
Beukers R; van Zanten RA; Schalm SW
J Hepatol; 1992 Jan; 14(1):22-9. PubMed ID: 1737913
[TBL] [Abstract][Full Text] [Related]
39. Serum type I collagen and N-terminal peptide of type III procollagen in patients with alcoholic liver disease: relationship to liver histology.
Trinchet JC; Hartmann DJ; Pateron D; Munz-Gotheil C; Callard P; Ville G; Beaugrand M
Alcohol Clin Exp Res; 1992 Apr; 16(2):342-6. PubMed ID: 1590556
[TBL] [Abstract][Full Text] [Related]
40. Type III procollagen peptide: a marker of disease activity and prognosis in primary biliary cirrhosis.
Babbs C; Smith A; Hunt LP; Rowan BP; Haboubi NY; Warnes TW
Lancet; 1988 May; 1(8593):1021-4. PubMed ID: 2896870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
